Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,121 across all filing types
Latest filing 2007-06-26 Capital/Financing Update
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Admission to Official List 1 page ?Kb
Capital/Financing Update Classification · 95% confidence The document is a market release announcing the admission of HalcyGen Pharmaceuticals Limited to the official list of ASX Limited, including details about the commencement of official quotation of shares and share issuance under a prospectus. It is a regulatory announcement about listing and share issuance, not a financial report or detailed filing. The document is short (588 characters) and serves as an announcement rather than a report. This fits best under Capital/Financing Update (CAP) as it relates to share issuance and listing on the exchange.
2007-06-26 English
Pre-Quotation Disclosure 1 page ?Kb
Regulatory Filings Classification · 95% confidence The document is titled 'MARKET RELEASE' and dated 27 June 2007. It is a pre-quotation disclosure related to the admission of HalcyGen Pharmaceuticals Limited to the Official List of ASX Limited. The document lists items such as distribution schedule, top 20 holders, terms of employee share option plans, corporate governance statements, escrow details, and importantly, references the audited financial report for the year ended 30 June 2006 and the reviewed financial report for the period ended 31 December 2006. However, the document itself does not contain the full financial reports but rather announces the pre-quotation disclosure and references these reports. The document length is short (1494 characters), and it serves as an announcement rather than the full report. According to the 'MENU VS MEAL' rule, this is a report publication announcement or regulatory filing rather than the full annual or interim report. Given the nature and content, the best fit is Regulatory Filings (RNS) as a general announcement of disclosures related to listing and pre-quotation information.
2007-06-26 English
Distribution Schedule 1 page ?Kb
Fund Information / Factsheet Classification · 90% confidence The document is very short (575 characters) and contains a distribution schedule showing the number of holders in various shareholding categories. There is no indication of financial data, management discussion, voting results, or any regulatory announcements. It is essentially a summary of shareholder distribution. This type of document is best classified as a Fund Information / Factsheet (FS), which typically includes brief summaries of key company facts and shareholder information.
2007-06-26 English
Top 20 shareholders 1 page ?Kb
Major Shareholding Notification Classification · 95% confidence The document contains a table listing the top 20 shareholders of HalcyGen Pharmaceuticals Limited, showing the number of shares held and percentage holdings. This is a notification of significant share ownership levels but does not indicate a change event or a detailed report. The document is short (2540 characters) and focuses solely on shareholding information. This fits the definition of a Major Shareholding Notification (MRQ), which involves notification of changes or status of significant share ownership levels.
2007-06-26 English
Employee Share Option Plan 26 pages ?Kb
Governance Information Classification · 95% confidence The document is titled 'Rules of the HalcyGen Pharmaceuticals Limited Employee Share Option Plan' and contains detailed provisions about the employee share option plan, including eligibility, invitations, applications, transfer, exercise, adjustments, amendments, administration, and definitions. It is a comprehensive set of rules governing an employee share option plan rather than a financial report, announcement, or regulatory filing. It does not contain financial statements, audit information, earnings data, or voting results. It is a governance-related document detailing internal rules and procedures related to employee share options. Therefore, the most appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2007-06-26 English
Option Terms 16 pages ?Kb
Governance Information Classification · 95% confidence The document is titled 'OPTION TERMS' and details the terms and conditions related to options granted to company directors, including definitions, exercise periods, exercise prices, transferability, adjustments, and notices. It is a legal and governance-related document outlining the rights and obligations concerning share options. There is no financial performance data, earnings information, or regulatory filing announcements. The content focuses on governance and management of share options granted to directors, which aligns with governance-related disclosures rather than financial reports or announcements. Therefore, the document best fits the category of Governance Information (CGR).
2007-06-26 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.